Trial
NCT03300505
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
ARRx
Why stopped
Cancelled by the sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-13